Pfizer Ltd PFIZER
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 4,113.35
- Day Range
- INR 4,075.10–4,117.95
- 52-Week Range
- INR 3,690.00–5,000.00
- Bid/Ask
- INR 4,102.20 / INR 4,105.10
- Market Cap
- INR 187.67 Bil
- Volume/Avg
- 7,965 / 32,432
Key Statistics
- Price/Earnings (Normalized)
- 36.22
- Price/Sales
- 8.48
- Dividend Yield (Trailing)
- 0.85%
- Dividend Yield (Forward)
- 0.85%
- Total Yield
- 0.85%
Company Profile
Pfizer Ltd is a major drug manufacturing company that focuses on a global portfolio of medical products. The company works across developed and emerging markets to advance treatments through its two segments, Pfizer Innovative Health and Pfizer Essential Health. The vast majority of the company's revenue is derived from the manufacture and sale of biopharmaceutical products. most of the company's sales are generated by its Innovative Health segment. While the company operates across a wide span of international markets, most of the company's revenue is generated in India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,285
- Website
- https://www.pfizerltd.co.in
Comparables
Valuation
|
Metric
|
PFIZER
|
506820
|
500674
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.22 | 70.13 | 32.91 |
Price/Book Value | 5.75 | 20.19 | 19.22 |
Price/Sales | 8.48 | 11.05 | 6.84 |
Price/Cash Flow | 45.72 | 90.70 | 33.77 |
Price/Earnings
PFIZER
506820
500674
Financial Strength
|
Metric
|
PFIZER
|
506820
|
500674
|
|---|---|---|---|
Quick Ratio | 3.39 | 1.52 | 0.84 |
Current Ratio | 4.15 | 2.19 | 1.92 |
Interest Coverage | 61.69 | 123.37 | 498.35 |
Quick Ratio
PFIZER
506820
500674
Profitability
|
Metric
|
PFIZER
|
506820
|
500674
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | 33.74% |
Return on Equity (Normalized) | — | — | 60.37% |
Return on Invested Capital (Normalized) | — | — | 58.05% |
Return on Assets
PFIZER
506820
500674
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Ksfcbjsjj | Gccp | $709.2 Bil | |
JNJ
| Johnson & Johnson | Bszdtcrm | Hcry | $351.2 Bil | |
MRK
| Merck & Co Inc | Ptknklbdd | Mgc | $317.2 Bil | |
ABBV
| AbbVie Inc | Lkxtdyh | Lmwjn | $291.6 Bil | |
AZN
| AstraZeneca PLC ADR | Cxpkxlpzx | Rlfhc | $210.7 Bil | |
RHHBY
| Roche Holding AG ADR | Dcdhjqsdsc | Qpb | $194.6 Bil | |
NVS
| Novartis AG ADR | Vxwmjnxhc | Sgjk | $189.7 Bil | |
PFE
| Pfizer Inc | Pxptrqpxl | Dpvz | $143.8 Bil | |
AMGN
| Amgen Inc | Ykrylpwv | Gjvd | $140.9 Bil | |
SNY
| Sanofi SA ADR | Qvbzhndr | Skj | $113.5 Bil |